Fetal growth and subsequent maternal risk of thyroid cancer

International Journal of Cancer

Volumn 138, Issue 5, 2016, Pages 1085-1093

  Crump, Casey ^a   Sundquist, Jan ^b   Sieh, Weiva ^c   Winkleby, Marilyn A ^a   Sundquist, Kristina ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY   (United States)

Author keywords

fetal development; mothers; pregnancy; risk factors; thyroid neoplasms

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY WEIGHT; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FETUS; FETUS GROWTH; FOLLOW UP; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING HABIT; SOCIAL ASPECT; SWEDEN; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; ADOLESCENT; AGED; FETUS DEVELOPMENT; MIDDLE AGED; RISK; THYROID NEOPLASMS;

ADOLESCENT; ADULT; AGED; BIRTH WEIGHT; COHORT STUDIES; FEMALE; FETAL DEVELOPMENT; HUMANS; MIDDLE AGED; PREGNANCY; RISK; THYROID NEOPLASMS;

EID: 84955511070     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29857     Document Type: Article

References (53)

1. Sipos JA, Mazzaferri EL., Thyroid cancer epidemiology and prognostic variables. Clin Oncol 2010; 22: 395-404.
2. Pellegriti G, Frasca F, Regalbuto C, et al., Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013; 2013: 965212.
3. Nagataki S, Nystrom E., Epidemiology and primary prevention of thyroid cancer. Thyroid Off J Am Thyroid Assoc 2002; 12: 889-96.
4. Kitahara CM, Gamborg M, Berrington de Gonzalez A, et al., Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. Cancer Res 2014; 74: 235-42.
5. Jing Z, Hou X, Liu Y, et al., Association between height and thyroid cancer risk: a meta-analysis of prospective cohort studies. Int J Cancer J Int Du Cancer 2015; 137: 1484-90.
6. Peterson E, De P, Nuttall R., BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PloS One 2012; 7: e29177.
7. Renehan AG, Tyson M, Egger M, et al., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-78.
8. Clavel-Chapelon F, Guillas G, Tondeur L, et al., Risk of differentiated thyroid cancer in relation to adult weight, height and body shape over life: the French E3N cohort. Int J Cancer J Int Du Cancer 2010; 126: 2984-90.
9. Leitzmann MF, Brenner A, Moore SC, et al., Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer J Int Du Cancer 2010; 126: 2947-56.
10. Meinhold CL, Ron E, Schonfeld SJ, et al., Nonradiation risk factors for thyroid cancer in the US radiologic technologists study. Am J Epidemiol 2010; 171: 242-52.
11. Vella V, Sciacca L, Pandini G, et al., The IGF system in thyroid cancer: new concepts. Mol Pathol 2001; 54: 121-4.
12. Ciampolillo A, De Tullio C, Giorgino F., The IGF-I/IGF-I receptor pathway: implications in the pathophysiology of thyroid cancer. Curr Med Chem 2005; 12: 2881-91.
13. Lagiou P, Samoli E, Hsieh CC, et al., Maternal and cord blood hormones in relation to birth size. Eur J Epidemiol 2014; 29: 343-51.
14. Vatten LJ, Nilsen ST, Odegard RA, et al., Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics 2002; 109: 1131-5.
15. Clapp JF, III, Schmidt S, Paranjape A, et al., Maternal insulin-like growth factor-I levels (IGF-I) reflect placental mass and neonatal fat mass. Am J Obstet Gynecol 2004; 190: 730-6.
16. Marsal K, Persson PH, Larsen T, et al., Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843-8.
17. Curado MP, Edwards B, Shin HR, et al., Cancer incidence in five continents, vol. 9 (Cancer IAfRo, ed). Lyon, France: International Agency for Research on Cancer, 2007.
18. Pickett KE, Abrams B, Selvin S., Maternal height, pregnancy weight gain, and birthweight. Am J Hum Biol Off J Hum Biol Council 2000; 12: 682-7.
19. Mesman I, Roseboom TJ, Bonsel GJ, et al., Maternal pre-pregnancy body mass index explains infant's weight and BMI at 14 months: results from a multi-ethnic birth cohort study. Arch Dis Childhood 2009; 94: 587-95.
20. Juarez SP, Merlo J., Revisiting the effect of maternal smoking during pregnancy on offspring birthweight: a quasi-experimental sibling analysis in Sweden. PloS One 2013; 8: e61734.
21. Kreiger N, Parkes R., Cigarette smoking and the risk of thyroid cancer. Eur J Cancer 2000; 36: 1969-73.
22. Rossing MA, Cushing KL, Voigt LF, et al., Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology 2000; 11: 49-54.
23. Makgoba M, Savvidou MD, Steer PJ., The effect of maternal characteristics and gestational diabetes on birthweight. BJOG Int J Obstet Gynaecol 2012; 119: 1091-7.
24. Yeo Y, Ma SH, Hwang Y, et al., Diabetes mellitus and risk of thyroid cancer: a meta-analysis. PloS One 2014; 9: e98135.
25. Rubin DB., Multiple imputation for nonresponse in surveys, ed. New York: Wiley, 1987.
26. StataCorp. Stata Statistical Software: release, 13th edn. College Station, TX: StataCorp LP, 2013.
27. Zou G., A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-6.
28. Troisi R, Doody DR, Mueller BA., A linked-registry study of gestational factors and subsequent breast cancer risk in the mother. Cancer Epidemiol Biomarkers Prevent 2013; 22: 835-47.
29. Cnattingius S, Torrang A, Ekbom A, et al., Pregnancy characteristics and maternal risk of breast cancer. JAMA J Am Med Assoc 2005; 294: 2474-80.
30. Wohlfahrt J, Melbye M., Maternal risk of breast cancer and birth characteristics of offspring by time since birth. Epidemiology 1999; 10: 441-4.
31. Innes KE, Byers TE., First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer J Int Du Cancer 2004; 112: 306-11.
32. Olsen J, Storm H., Pregnancy experience in women who later developed oestrogen-related cancers (Denmark). Cancer Causes Control 1998; 9: 653-7.
33. Troisi R, Potischman N, Roberts J, et al., Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States). Cancer Causes Control 2003; 14: 347-55.
34. Peck JD, Hulka BS, Savitz DA, et al., Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy. Am J Epidemiol 2003; 157: 258-66.
35. Nagata C, Iwasa S, Shiraki M, et al., Estrogen and alpha-fetoprotein levels in maternal and umbilical cord blood samples in relation to birth weight. Cancer Epidemiol Biomarkers Prevent 2006; 15: 1469-72.
36. Pollak MN, Schernhammer ES, Hankinson SE., Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004; 4: 505-18.
37. Maiorano E, Ciampolillo A, Viale G, et al., Insulin-like growth factor 1 expression in thyroid tumors. Appl Immunohistochem Mol Morphol 2000; 8: 110-9.
38. Schmidt JA, Allen NE, Almquist M, et al., Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prevent 2014; 23: 976-85.
39. Endogenous Hormones Breast Cancer Collaborative Group, Key TJ, Appleby PN, et al., Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11: 530-42.
40. Wei EK, Ma J, Pollak MN, et al., A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prevent 2005; 14: 850-5.
41. Samanic C, Chow WH, Gridley G, et al., Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006; 17: 901-9.
42. Kravdal O, Glattre E, Haldorsen T., Positive correlation between parity and incidence of thyroid cancer: new evidence based on complete Norwegian birth cohorts. Int J Cancer J Int Du Cancer 1991; 49: 831-6.
43. Galanti MR, Lambe M, Ekbom A, et al., Parity and risk of thyroid cancer: a nested case-control study of a nationwide Swedish cohort. Cancer Causes Control 1995; 6: 37-44.
44. Truong T, Orsi L, Dubourdieu D, et al., Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 2005; 161: 1056-65.
45. Negri E, Dal Maso L, Ron E, et al., A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999; 10: 143-55.
46. Rossing MA, Voigt LF, Wicklund KG, et al., Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000; 151: 765-72.
47. Derwahl M, Nicula D., Estrogen and its role in thyroid cancer. Endocrine Related Cancer 2014; 21: T273-83.
48. Zahid M, Goldner W, Beseler CL, et al., Unbalanced estrogen metabolism in thyroid cancer. Int J Cancer J Int Du Cancer 2013; 133: 2642-9.
49. Dong W, Zhang H, Li J, et al., Estrogen induces metastatic potential of papillary thyroid cancer cells through estrogen receptor alpha and beta. Int J Endocrinol 2013; 2013: 941568.
50. Kilfoy BA, Zheng T, Holford TR, et al., International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009; 20: 525-31.
51. National Board of Health and Welfare, Centre for Epidemiology. The Swedish Medical Birth Registry-a summary of content and quality, 2003. Available at: https://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/10655/2003-112-3-20031123.pdf.
52. Statistics Sweden. Cancer Incidence in Sweden 2009. Stockholm, 2009. Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18204/2010-12-17.pdf.
53. Schneider AB, Sarne DH., Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Practice Endocrinol Metab 2005; 1: 82-91.